4//SEC Filing
HOLUBIAK MYRON Z 4
Accession 0001213900-24-030812
CIK 0001506251other
Filed
Apr 4, 8:00 PM ET
Accepted
Apr 5, 4:05 PM ET
Size
27.1 KB
Accession
0001213900-24-030812
Insider Transaction Report
Form 4
HOLUBIAK MYRON Z
DirectorVice Chairman
Transactions
- Disposition to Issuer
Warrant to Purchase Common Stock
2024-04-03−129,450→ 0 totalExercise: $1.42Exp: 2024-04-05→ Common Stock (129,450 underlying) - Award
Warrant to Purchase Common Stock
2024-04-03+129,450→ 129,450 totalExercise: $1.42Exp: 2025-04-05→ Common Stock (129,450 underlying)
Holdings
- 1,992,243
Common Stock
- 15,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (15,000 underlying) - 40,000
Stock Option (Right to Purchase Common Stock)
Exercise: $3.45Exp: 2027-09-13→ Common Stock (40,000 underlying) - 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.70Exp: 2033-10-10→ Common Stock (400,000 underlying) - 400,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.25Exp: 2032-10-04→ Common Stock (400,000 underlying) - 650,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.04Exp: 2031-10-11→ Common Stock (650,000 underlying) - 784,314
Warrant to Purchase Common Stock
Exercise: $1.15Exp: 2024-08-14→ Common Stock (784,314 underlying) - 10,000(indirect: See footnote)
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (10,000 underlying) - 200,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.01Exp: 2030-10-06→ Common Stock (200,000 underlying) - 150,000
Stock Option (Right to Purchase Common Stock)
Exercise: $1.62Exp: 2028-09-04→ Common Stock (150,000 underlying) - 26,667
Stock Option (Right to Purchase Common Stock)
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 300,000
Stock Option (Right to Purchase Common Stock)
Exercise: $2.00Exp: 2031-07-22→ Common Stock (300,000 underlying) - 175,000
Stock Option (Right to Purchase Common Stock)
Exercise: $0.67Exp: 2029-10-08→ Common Stock (175,000 underlying) - 558,597
Warrant to Purchase Common Stock
Exercise: $0.77Exp: 2024-09-27→ Common Stock (558,597 underlying)
Footnotes (12)
- [F1]The two reported transactions involved an amendment of an outstanding warrant to extend the termination date from April 5, 2024 to April 5, 2025, which resulted in the cancellation of the "old" warrant and the grant of a replacement warrant. The warrant was originally issued on April 3, 2019 and was exercisable immediately.
- [F10]The options vested in full on September 4, 2021.
- [F11]The options vested in full on September 13, 2020.
- [F12]The options vested in full on December 31, 2016.
- [F2]The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F3]The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F4]The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F5]The options are held by the Reporting Person's daughter. The Reporting Person disclaims beneficial ownership in these shares.
- [F6]The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
- [F7]The options vested in full on October 6, 2023.
- [F8]The options vested in full on October 8, 2022.
- [F9]The warrant is fully vested and exercisable immediately.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001199080
Filing Metadata
- Form type
- 4
- Filed
- Apr 4, 8:00 PM ET
- Accepted
- Apr 5, 4:05 PM ET
- Size
- 27.1 KB